OBJECTIVE: To (a) compare the size of the dorsal and ventral striatum (caudate and putamen) in a large sample of antipsychotic-naïve individuals with schizotypal personality disorder (SPD) and healthy control participants; (b) examine symptom correlates of striatal size in SPD. METHODS: The left and right caudate and putamen were hand-traced on structural MRI at five dorsal to ventral slice levels in 76 SPD and 148 healthy control participants. A Group×Region (caudate, putamen)×Slice (1-5: ventral, 2, 3, 4, dorsal)×Hemisphere (left, right) mixed-model MANOVA was conducted on size relative to whole brain. RESULTS: Primary results showed that compared with the controls, the SPD group showed (a) larger bilateral putamen size overall and this enlargement was more pronounced at the most ventral and dorsal levels; in contrast, there were no between-group differences in caudate volume; (b) larger bilateral size of the striatum ventrally, averaged across the caudate and putamen. Among the SPD group, larger striatal size ventrally, particularly in the left hemisphere was associated with less severe paranoid symptoms. CONCLUSIONS: Striatal size is abnormal in SPD and resembles that of patients with schizophrenia who respond well to antipsychotic treatment. The results suggest that striatal size may be an important endophenotype to consider when developing new pharmacological treatments and when studying factors mitigating psychosis. Published by Elsevier B.V.
OBJECTIVE: To (a) compare the size of the dorsal and ventral striatum (caudate and putamen) in a large sample of antipsychotic-naïve individuals with schizotypal personality disorder (SPD) and healthy control participants; (b) examine symptom correlates of striatal size in SPD. METHODS: The left and right caudate and putamen were hand-traced on structural MRI at five dorsal to ventral slice levels in 76 SPD and 148 healthy control participants. A Group×Region (caudate, putamen)×Slice (1-5: ventral, 2, 3, 4, dorsal)×Hemisphere (left, right) mixed-model MANOVA was conducted on size relative to whole brain. RESULTS: Primary results showed that compared with the controls, the SPD group showed (a) larger bilateral putamen size overall and this enlargement was more pronounced at the most ventral and dorsal levels; in contrast, there were no between-group differences in caudate volume; (b) larger bilateral size of the striatum ventrally, averaged across the caudate and putamen. Among the SPD group, larger striatal size ventrally, particularly in the left hemisphere was associated with less severe paranoid symptoms. CONCLUSIONS: Striatal size is abnormal in SPD and resembles that of patients with schizophrenia who respond well to antipsychotic treatment. The results suggest that striatal size may be an important endophenotype to consider when developing new pharmacological treatments and when studying factors mitigating psychosis. Published by Elsevier B.V.
Authors: Anissa Abi-Dargham; Osama Mawlawi; Ilise Lombardo; Roberto Gil; Diana Martinez; Yiyun Huang; Dah-Ren Hwang; John Keilp; Lisa Kochan; Ronald Van Heertum; Jack M Gorman; Marc Laruelle Journal: J Neurosci Date: 2002-05-01 Impact factor: 6.167
Authors: Handan Gunduz; Huwei Wu; Manzar Ashtari; Bernhard Bogerts; David Crandall; Delbert G Robinson; Jose Alvir; Jeffrey Lieberman; John Kane; Robert Bilder Journal: Biol Psychiatry Date: 2002-05-15 Impact factor: 13.382
Authors: James J Levitt; Robert W McCarley; Chandlee C Dickey; Martina M Voglmaier; Margaret A Niznikiewicz; Larry J Seidman; Yoshio Hirayasu; Aleksandra A Ciszewski; Ron Kikinis; Ferenc A Jolesz; Martha E Shenton Journal: Am J Psychiatry Date: 2002-07 Impact factor: 18.112
Authors: Vivian Mitropoulou; Phillip D Harvey; Liza A Maldari; Patrick J Moriarty; Antonia S New; Jeremy M Silverman; Larry J Siever Journal: Biol Psychiatry Date: 2002-12-15 Impact factor: 13.382
Authors: J E Downhill; M S Buchsbaum; E A Hazlett; S Barth; S Lees Roitman; M Nunn; O Lekarev; T Wei; L Shihabuddin; V Mitropoulou; J Silverman; L J Siever Journal: Schizophr Res Date: 2001-03-30 Impact factor: 4.939
Authors: Larry J Siever; Harold W Koenigsberg; Philip Harvey; Vivian Mitropoulou; Marc Laruelle; Anissa Abi-Dargham; Marianne Goodman; Monte Buchsbaum Journal: Schizophr Res Date: 2002-03-01 Impact factor: 4.939
Authors: Monte S Buchsbaum; Igor Nenadic; Erin A Hazlett; Jacqueline Spiegel-Cohen; Michael B Fleischman; Arash Akhavan; Jeremy M Silverman; Larry J Siever Journal: Schizophr Res Date: 2002-03-01 Impact factor: 4.939
Authors: Ganesh B Chand; Dominic B Dwyer; Guray Erus; Aristeidis Sotiras; Erdem Varol; Dhivya Srinivasan; Jimit Doshi; Raymond Pomponio; Alessandro Pigoni; Paola Dazzan; Rene S Kahn; Hugo G Schnack; Marcus V Zanetti; Eva Meisenzahl; Geraldo F Busatto; Benedicto Crespo-Facorro; Christos Pantelis; Stephen J Wood; Chuanjun Zhuo; Russell T Shinohara; Haochang Shou; Yong Fan; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite; Nikolaos Koutsouleris; Daniel H Wolf; Christos Davatzikos Journal: Brain Date: 2020-03-01 Impact factor: 13.501